Sansure, a leading provider of biotechnology solutions, has unveiled its latest line of portable PCR (Polymerase Chain Reaction) instruments that are poised to redefine the landscape of diagnostic testing. These state-of-the-art portable PCR machine series, the S-Q31A and S-Q31B, boast a range of advanced features that make them ideal for a diverse array of medical and research applications.
Unparalleled Performance and Versatility
Both the S-Q31A and S-Q31B models are equipped with real-time PCR detection platforms, ensuring rapid and accurate results. Featuring liquid metal coated ceramic heating and air cooling technology, these instruments can achieve remarkable heating and cooling rates, allowing for efficient and precise temperature control during the amplification process. With the ability to detect single copy genes, the Sansure PCR machines offer exceptional sensitivity, making them suitable for a wide range of diagnostic tests, from respiratory infections to human papillomavirus (HPV) and sexually transmitted infections (STIs).
Compact and Portable Design
Recognizing the importance of mobility and accessibility in modern diagnostic testing, Sansure has designed these PCR instruments with a compact and portable footprint. The S-Q31A measures 230*284*376 mm and weighs 9.7 kg, while the S-Q31B is slightly larger at 336.5*280*435 mm and 13 kg. This versatile design allows healthcare professionals and researchers to easily transport the instruments to various locations, enabling on-site testing and rapid response capabilities.
Expanding Diagnostic Capabilities
The Sansure PCR machines support a comprehensive test menu, covering a diverse range of medical conditions. From respiratory infections such as SARS-CoV-2, influenza, and pneumonia to HPV and children’s health markers like Epstein-Barr virus and cytomegalovirus, these instruments provide a one-stop solution for efficient and reliable diagnostic testing. Furthermore, the company is actively developing additional test projects to broaden the applications of their cutting-edge technology.
Conclusion
Sansure’s commitment to innovation and accessibility is evident in the development of these portable PCR instruments. By leveraging advanced technologies and a modular design, the company has successfully bridged the gap between the high-end laboratory setting and primary healthcare facilities, empowering healthcare professionals to deliver accurate and timely diagnoses, even in remote or resource-limited areas.
